Esculentin (1-21)
General Information
DCTPep ID DCTPep01005
Peptide Name Esculentin (1-21)
Sequence GIFSKLAGKKIKNLLISGLKG
Sequence Length 21
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
ACP Tumor active peptide
Activity Information
Cell Line | Disease | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|
A549 | Lung adenocarcinoma | 50% Cell death=150 µM | MTT assay | 24h | 1 |
Hemolytic Activity Sheep erythrocytes: 10% Hemolysis=64 µM
Normal (non-cancerous) Cytotoxicity HaCat: 20% Killing=64 µM
Target Not available
Affinity Not available
Mechanism Not available
Structure Information
PDB ID Not available
Predicted Structure DCTPep01005
(Please note that there is the predicted structure, predicted by AlphaFold)
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Amidation
Other Modification None
Chiral L
Physicochemical Information
Formula C102H181N27O25
Absent amino acids CDEHMPQRTVWY
Theoretical pI 10.60
Acidic residues 0
Basic residues 5
Polar residues 7
Molecular weight (Average) 2185.72
Molecular weight (Monoisotopic) 2184.37
Common amino acids K
Net charge 5
Instability index (II) -18.78
Aliphatic index 134.76
Grand average of hydropathicity (GRAVY) 0.338
Half Life
30 hours (mammalian reticulocytes, in vitro).
>20 hours (yeast, in vivo).
>10 hours (Escherichia coli, in vivo).
Extinction coefficients
Should not be visible by UV spectrophotometry.
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 32722535
Title Frog Skin-Derived Peptides Against Corynebacterium jeikeium: Correlation between Antibacterial and Cytotoxic Activities
Doi 10.3390/antibiotics9080448
Year 2020
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available